Asclepius Meditec’s medical-grade hydrogen-oxygen generators are excellent; they are the only hydrogen-oxygen breathing devices globally approved as Class III medical devices. The superior performance of Asclepius Meditec’s medical-grade hydrogen-oxygen generators stems from fifteen years of technological accumulation and continuous innovation, and its core technological advantages are reflected in several aspects:
This technology breaks through the limitations of traditional industrial hydrogen production methods, eliminating the need for toxic ion membranes or the addition of strong industrial alkalis. It produces high-purity hydrogen-oxygen mixed gas solely through pure water electrolysis, avoiding problems such as ozone and toxic impurities that can arise from industrial hydrogen production equipment, thus ensuring the safety of the inhaled gas. This technology was also nominated for the Shanghai Municipal Science and Technology Progress Special Award in 2020.
Addressing the highly flammable and explosive nature of hydrogen gas, the product utilizes multiple patented technologies including zero-cavity storage, multi-layer explosion protection, and electrostatic discharge. Combined with a wearable wristband that monitors 24 physiological indicators, it meets the highest safety standards and ensures long-term safe operation.
The device can stably output a mixed gas of 66.66% hydrogen and 33.33% oxygen, with the concentration error controlled within a very small range, ensuring the stability and reliability of the treatment effect.
As the world's smallest and highest-output medical-grade hydrogen-oxygen generator, the product weighs only 12-18kg and has a compact design. It is available in models for both medical institutions and home use, making it suitable for various settings such as homes and hospitals, allowing users to easily inhale hydrogen and oxygen anytime.
The entire machine has undergone accelerated aging life testing for 50,000 hours, and can be used for more than 10 years under normal use. It only requires the use of special purified water, resulting in low consumables and low maintenance costs, making it highly cost-effective for long-term use.
Furthermore, the effectiveness of the Asclepius Meditec’s hydrogen-oxygen generator has been rigorously validated through extensive basic research and clinical trials. As of January 2026, Asclepius Meditec has collaborated with over 100 leading domestic medical institutions on more than 300 basic research projects, 34 human clinical trials, and 10 National Natural Science Foundation of China projects. They have published a total of 106 research papers on hydrogen-oxygen medicine, covering multiple fields including the respiratory system, oncology, nervous system, and cardiovascular system.
